Tobacco Approach Avoidance Training for Adolescent Smokers-2 (AAT-2)
This is a two part study. In Study 2, smokers who want to quit smoking will participate in a 4 week smoking cessation program combining weekly cognitive behavioral therapy (CBT) with weekly regular-AAT or placebo-AAT training. We hypothesize that adolescent smokers will exhibit stronger approach tendencies towards smoking-related stimuli in the tobacco Approach Avoidance Training (AAT) task when compared with nonsmokers and that adolescent smokers who are trained to avoid smoking related stimuli using the AAT will avoid tobacco approach tendencies in the AAT test trials and the Implicit Association Task, when compared to adolescent smokers who are not exposed to AAT training. We also hypothesize that adolescent smokers who are trained to avoid tobacco in a training AAT in combination with CBT will have better abstinence rates compared to those who receive placebo AAT training with CBT.
Tobacco Use Disorder
|Study Design:||Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Caregiver)
Primary Purpose: Treatment
|Official Title:||Tobacco Approach Avoidance Training for A Smoking Cessation in Adolescent Smokers- Study 2|
- Number of cigarettes smoked [ Time Frame: 4 weeks ] [ Designated as safety issue: No ]To evaluate if retraining automatic approach tendencies towards smoking stimuli, in combination with CBT, enhances an adolescent's ability to quit smoking following 4 weeks of treatment for smoking cessation.
|Study Start Date:||May 2012|
|Study Completion Date:||August 2013|
|Primary Completion Date:||May 2013 (Final data collection date for primary outcome measure)|
Experimental: AAT-avoid cigarette condition
Adolescent smokers are trained to avoid tobacco in a training AAT
This AAT condition trains kids to avoid cigarettes
|Placebo Comparator: AAT-no contingency continued assessment||
This AAT condition is a no contingency continued assessment version (50% approach-cigarettes, 50% avoid cigarettes).
Please refer to this study by its ClinicalTrials.gov identifier: NCT01625637
|United States, Connecticut|
|Yale University, School of Medicine, Department of Psychiatry|
|New Haven, Connecticut, United States, 06519|
|Principal Investigator:||Suchitra Krishnan-Sarin, Ph.D.||Yale University|